These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30864910)

  • 21. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder cancer: Mastering the immune microenvironment.
    Stone L
    Nat Rev Urol; 2017 Nov; 14(11):639. PubMed ID: 28994827
    [No Abstract]   [Full Text] [Related]  

  • 24. First-line systemic therapy trials for advanced transitional-cell carcinoma of the urothelium: should we stop separating cisplatin-eligible and -ineligible patients?
    Sonpavde G; Galsky MD; Vogelzang NJ
    J Clin Oncol; 2010 Sep; 28(25):e441-2; author reply e443-4. PubMed ID: 20644092
    [No Abstract]   [Full Text] [Related]  

  • 25. [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Seisen T; Cancel-Tassin G; Colin P; Cussenot O; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):943-53. PubMed ID: 25158326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p21(WAF-1/CIP-1), a downstream regulator of functional p53 loss, in transitional cell carcinoma of urothelium.
    Ozdemir E; Kakehi Y; Yoshida O
    Eur Urol; 2000 Aug; 38(2):230-4. PubMed ID: 10895017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
    Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
    Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extravesical Pagetoid Spread of Urothelial Carcinoma in Situ. A Report of Five Cases.
    Akgul M; Bomeisl PB; MacLennan GT
    Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):364-8. PubMed ID: 26860012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract.
    Hong JY; Choi MK; Uhm JE; Park MJ; Lee J; Park SH; Park JO; Kim WS; Kang WK; Lee HM; Choi HY; Lim H
    Med Oncol; 2009; 26(2):186-92. PubMed ID: 18988001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial Comment from Dr Sakano and Dr Matsuyama to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Sakano S; Matsuyama H
    Int J Urol; 2016 Mar; 23(3):231-2. PubMed ID: 26822627
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial Comment from Dr Miyata and Dr Sakai to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Miyata Y; Sakai H
    Int J Urol; 2016 Mar; 23(3):230-1. PubMed ID: 26840209
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas.
    Kubo H; Sumizawa T; Koga K; Nishiyama K; Takebayashi Y; Chuman Y; Furukawa T; Akiyama S; Ohi Y
    Int J Cancer; 1996 Dec; 69(6):488-94. PubMed ID: 8980253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
    Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
    Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Black PC; Seiler R
    Eur Urol; 2016 Dec; 70(6):1076. PubMed ID: 27567209
    [No Abstract]   [Full Text] [Related]  

  • 38. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
    Wu B; Cao X; Liang X; Zhang X; Zhang W; Sun G; Wang D
    PLoS One; 2015; 10(1):e0117510. PubMed ID: 25629735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidetector computed tomography urography (MDCTU) for diagnosing urothelial malignancy.
    Anderson EM; Murphy R; Rennie AT; Cowan NC
    Clin Radiol; 2007 Apr; 62(4):324-32. PubMed ID: 17331825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.